Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 25 | 51 | 54 | 54 | 63 | 67 | 69 | 71 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 4 |
| Total Liabilities | 37 | 63 | 67 | 66 | 76 | 80 | 82 | 88 |
| AssetsFixed Assets | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 4 | 9 | 9 | 8 | 9 | 2 | 2 | 2 |
| Other Assets | 30 | 55 | 58 | 58 | 67 | 78 | 80 | 86 |
| Total Assets | 37 | 63 | 67 | 66 | 76 | 80 | 82 | 88 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 10 | -1 | -28 | 22 | 1 | -39 | 36 | -2 |
| Cash from Investing | 6 | 1 | 23 | 1 | -1 | 5 | 6 | 2 |
| Cash from Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 11 | -1 | -2 | 22 | 1 | -39 | 37 | 0 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
TRANSCHEM · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.